Activation of farnesoid X receptor (FXR) protects against fructose-induced liver steatosis via inflammatory inhibition and ADRP reduction

Biochemical and Biophysical Research Communications

Volumn 450, Issue 1, 2014, Pages 117-123

  Liu, Xijun ^a   Xue, Ruyi ^b   Ji, Lingling ^a   Zhang, Xingwang ^a   Wu, Jian ^a,b   Gu, Jianxin ^a   Zhou, Meiling ^a   Chen, She ^a  

^a FUDAN UNIVERSITY   (China)

^b ZHONGSHAN HOSPITAL OF FUDAN UNIVERSITY   (China)

Author keywords

Adipose differentiation related protein; Farnesoid X receptor; Fructose; Non alcoholic fatty liver disease; WAY 362450

Indexed keywords

ADIPOPHILIN; ENDOTOXIN; FARNESOID X RECEPTOR; FRUCTOSE; LIPOPOLYSACCHARIDE; PALMITIC ACID; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA; TUROFEXORATE ISOPROPYL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; DRUG BINDING SITE; EXPERIMENTAL DIGESTIVE SYSTEM DISEASE; GENE EXPRESSION; HISTOPATHOLOGY; HUMAN; LIPID LIVER LEVEL; LIPID STORAGE; LIVER PROTECTION; MOUSE; NONALCOHOLIC FATTY LIVER; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RECEPTOR DOWN REGULATION; RECEPTOR UPREGULATION; TRIACYLGLYCEROL BLOOD LEVEL;

MUS;

ADIPOSE DIFFERENTIATION-RELATED PROTEIN; FARNESOID X RECEPTOR; FRUCTOSE; NON-ALCOHOLIC FATTY LIVER DISEASE; WAY-362450;

ANIMALS; AZEPINES; DOWN-REGULATION; DRUG-INDUCED LIVER INJURY; FATTY LIVER; FRUCTOSE; INDOLES; LIPOPOLYSACCHARIDES; MEMBRANE PROTEINS; MICE; RECEPTORS, CYTOPLASMIC AND NUCLEAR;

EID: 84904744146     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2014.05.072     Document Type: Article

References (26)

1. J.K. Dowman, J.W. Tomlinson, and P.N. Newsome Systematic review: the diagnosis and staging of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis Aliment. Pharmacol. Ther. 33 2011 525 540
2. J.B. Schwimmer, R. Deutsch, T. Kahen, J.E. Lavine, C. Stanley, and C. Behling Prevalence of fatty liver in children and adolescents Pediatrics 118 2006 1388 1393
3. B.M. Forman, E. Goode, J. Chen, A.E. Oro, D.J. Bradley, T. Perlmann, D.J. Noonan, L.T. Burka, T. McMorris, W.W. Lamph, R.M. Evans, and C. Weinberger Identification of a nuclear receptor that is activated by farnesol metabolites Cell 81 1995 687 693
4. T. Claudel, B. Staels, and F. Kuipers The farnesoid X receptor: a molecular link between bile acid and lipid and glucose metabolism Arterioscler. Thromb. Vasc. Biol. 25 2005 2020 2030
5. L. Adorini, M. Pruzanski, and D. Shapiro Farnesoid X receptor targeting to treat nonalcoholic steatohepatitis Drug Discov. Today 17 2012 988 997
6. M. Fuchs Non-alcoholic fatty liver disease: the bile acid-activated farnesoid X receptor as an emerging treatment target J. Lipids 2012 934396
7. S. Zhang, J. Wang, Q. Liu, and D.C. Harnish Farnesoid X receptor agonist WAY-362450 attenuates liver inflammation and fibrosis in murine model of non-alcoholic steatohepatitis J. Hepatol. 51 2009 380 388
8. R.J. Johnson, C. Rivard, M.A. Lanaspa, S. Otabachian-Smith, T. Ishimoto, C. Cicerchi, P.R. Cheeke, B. Macintosh, and T. Hess Fructokinase, fructans, intestinal permeability, and metabolic syndrome: an equine connection? J. Equine Vet. Sci. 33 2013 120 126
9. X. Ouyang, P. Cirillo, Y. Sautin, S. McCall, J.L. Bruchette, A.M. Diehl, R.J. Johnson, and M.F. Abdelmalek Fructose consumption as a risk factor for non-alcoholic fatty liver disease J. Hepatol. 48 2008 993 999
10. Y. Yilmaz Review article: fructose in non-alcoholic fatty liver disease Aliment. Pharmacol. Ther. 35 2012 1135 1144
11. A. Spruss, G. Kanuri, S. Wagnerberger, S. Haub, S.C. Bischoff, and I. Bergheim Toll-like receptor 4 is involved in the development of fructose-induced hepatic steatosis in mice Hepatology 50 2009 1094 1104
12. I. Bergheim, S. Weber, M. Vos, S. Kramer, V. Volynets, S. Kaserouni, C.J. McClain, and S.C. Bischoff Antibiotics protect against fructose-induced hepatic lipid accumulation in mice: role of endotoxin J. Hepatol. 48 2008 983 992
13. H.P. Jiang, S.E. Harris, and G. Serrero Molecular cloning of a differentiation-related mRNA in the adipogenic cell line 1246 Cell Growth Differ. 3 1992 21 30
14. D.L. Brasaemle, T. Barber, N.E. Wolins, G. Serrero, E.J. Blanchette-Mackie, and C. Londos Adipose differentiation-related protein is an ubiquitously expressed lipid storage droplet-associated protein J. Lipid Res. 38 1997 2249 2263
15. B. Magnusson, L. Asp, P. Bostrom, M. Ruiz, P. Stillemark-Billton, D. Linden, J. Boren, and S.O. Olofsson Adipocyte differentiation-related protein promotes fatty acid storage in cytosolic triglycerides and inhibits secretion of very low-density lipoproteins Arterioscler. Thromb. Vasc. Biol. 26 2006 1566 1571
16. W. Motomura, M. Inoue, T. Ohtake, N. Takahashi, M. Nagamine, S. Tanno, Y. Kohgo, and T. Okumura Up-regulation of ADRP in fatty liver in human and liver steatosis in mice fed with high fat diet Biochem. Biophys. Res. Commun. 340 2006 1111 1118
17. X. Ge, L. Yin, H. Ma, T. Li, J.Y. Chiang, and Y. Zhang Aldo-keto reductase 1B7 is a target gene of FXR and regulates lipid and glucose homeostasis J. Lipid Res. 52 2011 1561 1568
18. J. Laurencikiene, V. van Harmelen, E. Arvidsson Nordstrom, A. Dicker, L. Blomqvist, E. Naslund, D. Langin, P. Arner, and M. Ryden NF-kappaB is important for TNF-alpha-induced lipolysis in human adipocytes J. Lipid Res. 48 2007 1069 1077
19. Y. Imai, G.M. Varela, M.B. Jackson, M.J. Graham, R.M. Crooke, and R.S. Ahima Reduction of hepatosteatosis and lipid levels by an adipose differentiation-related protein antisense oligonucleotide Gastroenterology 132 2007 1947 1954
20. M. Ohhira, W. Motomura, M. Fukuda, T. Yoshizaki, N. Takahashi, S. Tanno, N. Wakamiya, Y. Kohgo, S. Kumei, and T. Okumura Lipopolysaccharide induces adipose differentiation-related protein expression and lipid accumulation in the liver through inhibition of fatty acid oxidation in mice J. Gastroenterol. 42 2007 969 978
21. M.F. Liu, L.X. Zu, C. Xu, S.S. Pu, and G.H. Xu Tumor necrosis factor-alpha upregulates the protein levels of adipose differentiation-related protein in rat differentiated adipocytes Beijing DaXue XueBao 40 2008 578 582
22. T. Inagaki, A. Moschetta, Y.K. Lee, L. Peng, G. Zhao, M. Downes, R.T. Yu, J.M. Shelton, J.A. Richardson, J.J. Repa, D.J. Mangelsdorf, and S.A. Kliewer Regulation of antibacterial defense in the small intestine by the nuclear bile acid receptor Proc. Natl. Acad. Sci. U.S.A. 103 2006 3920 3925
23. V. Volynets, A. Spruss, G. Kanuri, S. Wagnerberger, S.C. Bischoff, and I. Bergheim Protective effect of bile acids on the onset of fructose-induced hepatic steatosis in mice J. Lipid Res. 51 2010 3414 3424
24. W. Wu, X. Liu, X. Peng, R. Xue, L. Ji, X. Shen, S. Chen, J. Gu, and S. Zhang Bile acids override steatosis in farnesoid X receptor deficient mice in a model of non-alcoholic steatohepatitis Biochem. Biophys. Res. Commun. 448 2014 50-5
25. X.C. Morgan, T.L. Tickle, H. Sokol, D. Gevers, K.L. Devaney, D.V. Ward, J.A. Reyes, S.A. Shah, N. LeLeiko, S.B. Snapper, A. Bousvaros, J. Korzenik, B.E. Sands, R.J. Xavier, and C. Huttenhower Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment Genome Biol. 13 2012 R79
26. L. Miele, V. Valenza, G. La Torre, M. Montalto, G. Cammarota, R. Ricci, R. Masciana, A. Forgione, M.L. Gabrieli, G. Perotti, F.M. Vecchio, G. Rapaccini, G. Gasbarrini, C.P. Day, and A. Grieco Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease Hepatology 49 2009 1877 1887